Chimeron Bio Competitors and Similar CompaniesClear all

Chimeron Bio's competitors and similar companies include Ionis Pharmaceuticals, Rocket Pharmaceuticals, Mustang Bio and CRISPR Therapeutics.

	Chimeron Bio Chimeron Bio is a company focused on RNA (ribonucleic acid) therapeutics.	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	Rocket Pharmaceuticals Rocket Pharmaceuticals is a biotechnology company focused on seeking cures through molecular and gene therapy.	Mustang Bio Mustang Bio is a clinical-stage biopharmaceutical company that specializes in the development of cell and gene therapies.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date	Founding Date 2015	Founding Date 1989	Founding Date 2018	Founding Date 2015	Founding Date 2013
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Philadelphia, US HQ	Locations Carlsbad, US HQ Vancouver, CA Stuttgart, DE Dublin, IE Dublin, IE Lisboa, PT London, GB see more	Locations East Windsor, US HQ New York, US	Locations Worcester, US HQ	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US
Employees	Employees 12	Employees 1,40231% increase	Employees 5716% increase	Employees 693% decrease	Employees 393
Valuation ($)	Valuation ($) N/A	Valuation ($) 6.3 b	Valuation ($) 1.6 b	Valuation ($) 11.2 m	Valuation ($) 4.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $943.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $3.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $15.9m (FY, 2025)	Cost of goods $1.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Net income	Net income N/A	Net income ($381.4m) (FY, 2025)	Net income ($223.1m) (FY, 2025)	Net income ($1.9m) (FY, 2025)	Net income ($581.6m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 845k	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 127m